Project overview
Targeted molecular radiotherapy delivered by radiolabelled anti-CD66 as the only conditioning prior to autologous stem cell transplantation for AL-amyloidosis, a Phase I/IIa trial.
Staff
Lead researcher
- Choose your halls of residence
- Apply for accommodation
- Guaranteed accommodation
- Your accommodation options
- Accommodation for those with additional requirements
- International and pre-sessional students
- Postgraduate accommodation
- Couples and students with children
- Renting privately
- Our accommodation areas
- Privacy notice
- Terms and conditions
- Fees and contracts
Research project
A Phase I Study of Targeted Radiotherapy alone for Stem Cell Transplant Conditioning in Systemic AL Amyloidosis - 'TRALA'
-
Lead researcher:
-
Status:Not active